XML 33 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 1,280,370 $ 594,248
Short-term investment 39,399 39,375
Accounts receivable, net 308,439 246,519
Inventory 33,597 34,052
Prepaid expenses and other current assets 23,717 15,493
Total current assets 1,685,522 929,687
Equipment, net 11,904 11,867
Security deposit 12,000 12,000
Debt issuance costs, net 31,223 44,830
Totals 1,740,649 998,384
Current liabilities:    
Accounts payable and accrued expenses 217,591 306,144
Accrued interest, related party 34,767 28,636
Accrued interest    9,458
Related party accounts payable and accrued expenses 163,897 244,858
Related party notes payable 73,500 73,500
Convertible debentures, net of discounts of $0 and $269,388    1,802,612
Billings in excess of costs and estimated earnings on uncompleted contracts 4,882 24,349
Deferred revenue 325,714 379,765
Conversion option liabilities 519,946 2,873
Warrant liabilities 1,004,220 214,738
Total current liabilities 2,344,517 3,086,933
Convertible debentures, net of discounts of $951,357 3,044,343   
Total liabilities 5,388,860 3,086,933
Stockholders' deficiency:    
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 0 issued and outstanding at September 30, 2014 and December 31, 2013      
Common stock, $0.01 par value, 300,000,000 shares authorized; 42,773,093 issued and outstanding at September 30, 2014, 43,223,093 issued and outstanding at December 31, 2013 427,731 432,231
Additional paid-in capital 6,852,493 6,679,298
Accumulated deficiency (10,928,435) (9,200,078)
Total stockholders' deficiency (3,648,211) (2,088,549)
Totals $ 1,740,649 $ 998,384